TGF-β signaling inhibitors
JP2026119776AActive Publication Date: 2026-07-21AIBII KESHOHIN
View PDF 1 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- AIBII KESHOHIN
- Filing Date
- 2025-01-08
- Publication Date
- 2026-07-21
Smart Images
Figure 2026119776000001_ABST
Abstract
To provide a novel TGF-β signaling inhibitor. [Solution] The active ingredient is an aqueous extract of evening primrose. Since the aqueous extract of evening primrose has a TGF-β signaling inhibitory effect, it can be expected to have preventive and therapeutic effects on fibrotic diseases, as well as preventive and ameliorative effects on cellulite, by suppressing the promotion of fibrosis in tissues by TGF-β.
Need to check novelty before this filing date? Find Prior Art